Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

Colaboración

Año: 2022

de Miguel-Perez, D; Russo, A; Arrieta, O; Ak, M; Barron, F; Gunasekaran, M; Mamindla, P; Lara-Mejia, L; Peterson, CB; Er, ME; Peddagangireddy, V; Buemi, F; Cooper, B; Manca, P; Lapidus, RG; Hsia, RC; Cardona, AF; Naing, A; Kaushal, S; Hirsch, FR; Mack, PC; Serrano, MJ; Adamo, V; Colen, RR; Rolfo, C

Título: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

• D1